Literature DB >> 16586369

Progressive increase in point mutations associated with chloroquine resistance in Plasmodium falciparum isolates from India.

Pooja Mittra1, Sumiti Vinayak, Hina Chandawat, Manoj K Das, Neeru Singh, Sukla Biswas, Vas Dev, Ashwani Kumar, Musharraf A Ansari, Yagya D Sharma.   

Abstract

BACKGROUND: Effective malaria control programs require continuous monitoring of drug pressure in the field, using molecular markers.
METHODS: We used sequence analysis to investigate the pfcrt and pfmdr1 mutations in Indian Plasmodium falciparum isolates. To evaluate the chloroquine drug pressure in the field, isolates were collected from 5 different areas at 2 time points, with an interval of 2 years.
RESULTS: In 265 P. falciparum isolates, pfcrt mutations were observed at codons 72, 74, 75, 76, and 220, resulting in 8 different genotypes: SMNTS (61.89%), CIETS (12.08%), CMNKS (0.38%), CMNTA (2.64%), CMNTS (4.91%), SMNTA (0.38%), CIDTS (2.26%), and wild-type CMNKA (15.47%). During the 2-year period, there was a significant decrease in the number of isolates with the SMNTS genotype and an increase in the number of isolates with the highly chloroquine-resistant pfcrt genotype CIETS (P < .05). The N86Y mutation was less prevalent (30.13%) than the Y184F mutation (99.16%) in the pfmdr1 gene in 239 isolates, but the number of isolates with the N86Y mutation increased significantly during the 2-year period (P < .05). The number of isolates with higher total numbers of pfcrt and pfmdr1 2-loci mutations, therefore, increased significantly during this period. There was a regional bias in the mutation rate of these genes, because isolates from areas where chloroquine resistance was high had higher numbers of 2-loci mutations, and areas where chloroquine resistance was low had isolates with lower numbers of 2-loci mutations.
CONCLUSION: There was a temporal increase in the number of pfcrt and pfmdr1 2-loci mutations, and this led to the higher level of chloroquine resistance. This is a cause for concern for the antimalarial drug policy in India.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16586369     DOI: 10.1086/502979

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H+ exchanger.

Authors:  Hao Meng; Rongping Zhang; Henglin Yang; Qi Fan; Xinzhuan Su; Jun Miao; Liwang Cui; Zhaoqing Yang
Journal:  Antimicrob Agents Chemother       Date:  2010-07-19       Impact factor: 5.191

2.  Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India.

Authors:  Anwar Ahmed; Vanshika Lumb; Manoj K Das; Vas Dev; Yagya D Sharma
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

3.  Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.

Authors:  Pabitra Saha; Subhasish K Guha; Sonali Das; Shrabanee Mullick; Swagata Ganguly; Asit Biswas; Dilip K Bera; Gaurangadeb Chattopadhyay; Madhusudan Das; Pratip K Kundu; Krishnangshu Ray; Ardhendu K Maji
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

4.  Evidence of selective sweeps in genes conferring resistance to chloroquine and pyrimethamine in Plasmodium falciparum isolates in India.

Authors:  Tonya Mixson-Hayden; Vidhan Jain; Andrea M McCollum; Amanda Poe; Avinash C Nagpal; Aditya P Dash; Jonathan K Stiles; Venkatachalam Udhayakumar; Neeru Singh
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

5.  Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.

Authors:  Olusola Ojurongbe; Segun I Oyedeji; Wellington A Oyibo; Adetola F Fagbenro-Beyioku; Jürgen F Kun
Journal:  Wien Klin Wochenschr       Date:  2010-11-12       Impact factor: 1.704

6.  Quadruple mutations in dihydrofolate reductase of Plasmodium falciparum isolates from Car Nicobar Island, India.

Authors:  Anwar Ahmed; Manoj K Das; Vas Dev; Muheet A Saifi; Yagya D Sharma
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

7.  Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India.

Authors:  Narayani Prasad Kar; Kshipra Chauhan; Nutan Nanda; Ashwani Kumar; Jane M Carlton; Aparup Das
Journal:  Infect Genet Evol       Date:  2016-03-15       Impact factor: 3.342

8.  Multiple origins of Plasmodium falciparum dihydropteroate synthetase mutant alleles associated with sulfadoxine resistance in India.

Authors:  Vanshika Lumb; Manoj K Das; Neeru Singh; Vas Dev; Wajihullah Khan; Yagya D Sharma
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

9.  In vitro sensitivities of Plasmodium falciparum isolates from the China-Myanmar border to piperaquine and association with polymorphisms in candidate genes.

Authors:  Mingming Hao; Dandan Jia; Qing Li; Yongshu He; Lili Yuan; Shuhui Xu; Kexuan Chen; Jia Wu; Lijuan Shen; Lin Sun; Hongbin Zhao; Zhaoqing Yang; Liwang Cui
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

10.  Extensive genetic diversity in the Plasmodium falciparum Na+/H+ exchanger 1 transporter protein implicated in quinine resistance.

Authors:  Sumiti Vinayak; Mohammad Tauqeer Alam; Mala Upadhyay; Manoj K Das; Vas Dev; Neeru Singh; Aditya P Dash; Yagya D Sharma
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.